Clinical Trials Directory

Explore 118,444 clinical trials worldwide

Showing 90701-90750 of 118,444 trials

Active filters:Status: Recruiting, Active, not recruiting, Enrolling by invitation, Not yet recruiting

Clinical Trials (118,444)

NCT05057130
Neoadjuvant Combination of Doxorubicin, Cisplatin and Methotrexate in Patients Aged 24-40 Years With Primary Bone Tumors
PHASE2/PHASE3Recruiting
50 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2024
5 conditions1 sponsor1 location
NCT04605081
Pharmacological and Behavioral Treatments After Bariatric Surgery: Maintenance Treatment (Stage 2a)
PHASE2/PHASE3Enrolling by invitation
100 participants
Started: Jan 10, 2022 · Completed: May 31, 2027
2 conditions2 sponsors1 location
NCT04835129
Isatuximab, Pomalidomide, Elotuzumab and Dexamethasone in Relapsed and/or Refractory Multiple Myeloma
PHASE2Recruiting
53 participants
Started: Jan 10, 2022 · Completed: Jan 1, 2027
1 condition1 sponsor2 locations
NCT05074212
Aesthetic Outcome of Complex Linear Closure vs Second Intention Healing: Below the Knee
NAEnrolling by invitation
172 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2030
2 conditions1 sponsor1 location
NCT05057143
3D Printed Implants for the Defect Reconstruction in Patients With Chest Wall Tumors
NARecruiting
30 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2025
6 conditions1 sponsor1 location
NCT05094622
Physical Training in Patients With POTS After Covid-19
NAActive, not recruiting
30 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2025
3 conditions2 sponsors1 location
NCT06835023
Dextran 40 Plus Ringer's Lactate Vs. Ringer's Lactate Alone for Fluid Resuscitation in Acute Pancreatitis
NARecruiting
100 participants
Started: Jan 10, 2022 · Completed: May 12, 2025
3 conditions1 sponsor1 location
NCT06270017
Evaluation of Metastatic Disease and Oncological Treatment in Patients With Colon Cancer Using Zebra Fish Avatars
PHASE1/PHASE2Recruiting
300 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2028
1 condition1 sponsor1 location
NCT05339178
Quality of Life of Periodontitis Patients Visiting Supportive Periodontal Therapy
N/ARecruiting
300 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2033
2 conditions1 sponsor1 location
NCT05143736
Nasal and Gut Microbiota Combined Clinical Events Predicts the Prognosis of Septic Patients
N/ARecruiting
300 participants
Started: Jan 10, 2022 · Completed: Jan 31, 2025
2 conditions1 sponsor2 locations
NCT05163938
REThink Chronic-A Mobile Therapeutic Game
NAActive, not recruiting
158 participants
Started: Jan 10, 2022 · Completed: Jun 1, 2025
2 conditions1 sponsor1 location
NCT05436587
Mutations and Phenotypes of Unclassifiable Inherited Bone Marrow Failure Syndromes
N/ARecruiting
250 participants
Started: Jan 10, 2022 · Completed: Jan 31, 2028
1 condition3 sponsors1 location
NCT05218187
Robotic Gait Rehabilitation in Parkinson's Disease
NARecruiting
30 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT04858867
Reinducing Radioiodine-sensitivity in Radioiodine-refractory DTC Using Lenvatinib (RESET)
NARecruiting
12 participants
Started: Jan 10, 2022 · Completed: Jun 1, 2025
1 condition1 sponsor1 location
NCT05166226
PortionSize Study 2 Free-Living Evaluation
N/AActive, not recruiting
45 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05232968
Ameliorating Effects of Aging by Physical Exercise
NARecruiting
120 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2025
2 conditions2 sponsors1 location
NCT04803604
Decision Support Training for Advanced Cancer Family Caregivers: The CASCADE Factorial Trial
NARecruiting
256 participants
Started: Jan 10, 2022 · Completed: Jun 30, 2026
2 conditions2 sponsors2 locations
NCT05243966
Myriad™ Augmented Soft Tissue Reconstruction Registry
N/ARecruiting
800 participants
Started: Jan 10, 2022 · Completed: Jan 31, 2029
7 conditions1 sponsor11 locations
NCT04934358
Motivational Interventions and Physical Exercise in Patients With Fragility Fracture
NARecruiting
100 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2024
1 condition1 sponsor1 location
NCT04891068
BRE-04: Window of Opportunity Trial of Preoperative Low Dose Azacitidine in High-Risk Early Stage Breast Cancer
PHASE2Recruiting
40 participants
Started: Jan 10, 2022 · Completed: May 31, 2026
2 conditions1 sponsor1 location
NCT04463446
The Impact of an Innovative eHealth Transition Intervention on Self-Management Skills Among Young Adults With Congenital Heart Disease
NAActive, not recruiting
207 participants
Started: Jan 10, 2022 · Completed: Dec 30, 2025
2 conditions6 sponsors1 location
NCT05211206
IV Fluids and Post-ERCP Pancreatitis
N/ARecruiting
13,000 participants
Started: Jan 10, 2022 · Completed: Feb 28, 2026
1 condition6 sponsors1 location
NCT04964947
Tobramycin Injection to Prevent Infection in Open Fractures
PHASE3Active, not recruiting
600 participants
Started: Jan 10, 2022 · Completed: Jul 31, 2026
3 conditions2 sponsors3 locations
NCT05159960
Optimal Treatment Protocol for Selective Laser Trabeculoplasty - Repeat Trial
NAEnrolling by invitation
400 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2027
3 conditions2 sponsors2 locations
NCT05793333
Predictors of Node Positivity in Endometrial Cancer
N/ARecruiting
200 participants
Started: Jan 10, 2022 · Completed: Jan 1, 2025
1 condition1 sponsor1 location
NCT05166239
HAIC Combine With Lenvatinib and PD-1 Inhibitors for Advanced HCC With PVTT
PHASE2Recruiting
66 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2024
2 conditions1 sponsor1 location
NCT05163925
EUROSETS ECMO Study in Clinical Extracorporeal Life Support Applications
N/ARecruiting
30 participants
Started: Jan 10, 2022 · Completed: Jul 31, 2025
1 condition1 sponsor1 location
NCT05356806
Incidence of Peri-implant Mucositis in Patients With Treated Periodontitis
N/ARecruiting
277 participants
Started: Jan 10, 2022 · Completed: Jun 30, 2026
1 condition3 sponsors1 location
NCT03629327
Inducing Immune Quiescence the Genital Tract With ASA
NARecruiting
300 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2025
1 condition1 sponsor1 location
NCT05145023
Development and Validation of a Health-related Quality of Life Tool for Patients With Cardiac Sarcoidosis
N/ARecruiting
120 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2025
1 condition3 sponsors2 locations
NCT06109233
A Perspective Study of the MRD-tailored Therapy in Patients With Newly Diagnosed Multiple Myeloma With Persistent Minimal Residual Disease After Initial Treatment
N/ARecruiting
80 participants
Started: Jan 10, 2022 · Completed: Jan 10, 2026
2 conditions1 sponsor1 location
NCT05363657
International REgistry of COnservative or Radical Treatment of Localized Kidney Tumors
N/ARecruiting
10,000 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2028
1 condition3 sponsors37 locations
NCT05057195
Wide Excision of Soft Tissue Sarcomas in Combination With Interstitial Radiation Therapy
NARecruiting
78 participants
Started: Jan 10, 2022 · Completed: Dec 31, 2025
2 conditions1 sponsor1 location
NCT05750095
Enabling Parents of Children With Autism Spectrum Disorders - a Randomized Controlled Trial of Parenting Programs
NARecruiting
240 participants
Started: Jan 10, 2022 · Completed: Oct 30, 2028
1 condition6 sponsors3 locations
NCT05183724
Ovarian Function of Nasopharyngeal Carcinoma Women Survivors
N/ANot yet recruiting
602 participants
Started: Jan 10, 2022 · Completed: Jan 10, 2026
1 condition1 sponsor1 location
NCT05301543
Insomnia Behavioral Intervention Study
NARecruiting
20 participants
Started: Jan 10, 2022 · Completed: May 20, 2028
1 condition1 sponsor1 location
NCT06007456
Clinical, Laboratory and Ultrasound Stratification of Patients With Juvenile Idiopathic Arthritis
N/ARecruiting
80 participants
Started: Jan 10, 2022 · Completed: Mar 15, 2026
1 condition1 sponsor2 locations
NCT04798469
Pain Alleviation With Testosterone in Opioid-Induced Hypogonadism
PHASE2Recruiting
150 participants
Started: Jan 10, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT06292728
ENDOPLY System in Humans: a Pilot Study
NARecruiting
10 participants
Started: Jan 9, 2022 · Completed: Dec 31, 2025
1 condition2 sponsors1 location
NCT05147597
Turkish Validity and Reliability of SGRQ-I
N/ARecruiting
180 participants
Started: Jan 9, 2022 · Completed: Jan 1, 2026
1 condition1 sponsor1 location
NCT04690010
Ambulatory Versus Inpatient Percutaneous Nephrolithotomy
NAActive, not recruiting
140 participants
Started: Jan 8, 2022 · Completed: Dec 30, 2024
1 condition2 sponsors1 location
NCT05284656
Effect of Folic Acid and/or Pentoxifylline on Patients With Chronic Kidney Disease
PHASE3Active, not recruiting
80 participants
Started: Jan 8, 2022 · Completed: Dec 19, 2026
1 condition1 sponsor1 location
NCT05172999
Loxenatide Plus LNG-IUS in Endometrial Atypical Hyperplasia
PHASE2/PHASE3Active, not recruiting
30 participants
Started: Jan 8, 2022 · Completed: Jun 30, 2026
3 conditions1 sponsor1 location
NCT05186363
Effectiveness of Seasonal Malaria Chemoprevention in Nampula Province, Mozambique: Type Two Hybrid Implementation Study
PHASE4Active, not recruiting
3,156 participants
Started: Jan 8, 2022 · Completed: Dec 1, 2023
1 condition1 sponsor2 locations
NCT05182463
Peginterferon Treatment Study for Inactive Chronic Hepatitis B Patients
PHASE4Recruiting
5,000 participants
Started: Jan 8, 2022 · Completed: Nov 30, 2029
1 condition1 sponsor1 location
NCT05144841
A Study to Evaluate Zilovertamab Vedotin (MK-2140) for Relapsed or Refractory Diffuse Large B-Cell Lymphoma (DLBCL) (MK-2140-004)
PHASE2Active, not recruiting
140 participants
Started: Jan 8, 2022 · Completed: Jan 9, 2026
1 condition1 sponsor71 locations
NCT06313983
A Phase Ⅲ Study of Hemay022 in Combination With AI In Advanced Breast Cancer
PHASE3Recruiting
339 participants
Started: Jan 8, 2022 · Completed: Jun 30, 2026
1 condition1 sponsor1 location
NCT05562375
Predictive Value of GOCCLES® Device for Early Diagnosis of Oral Potentially Malignant Disorders
NARecruiting
73 participants
Started: Jan 8, 2022 · Completed: Sep 30, 2026
2 conditions1 sponsor1 location
NCT05134857
The Zonisamide and Reinforcement for Reducing Alcohol Use (ZARRA) Study
PHASE2Recruiting
205 participants
Started: Jan 7, 2022 · Completed: Aug 31, 2026
1 condition1 sponsor1 location
NCT06330441
Pancreatic Cancer Screening in a Population at High Risk
NARecruiting
700 participants
Started: Jan 7, 2022 · Completed: Jan 6, 2028
3 conditions2 sponsors1 location